Physician profile
Anil Patel
NPI 1265491351
$4,309.58
in general payments reported to CMS, 2019-2025
14 companies · $699 in 2025
The $699 reported for 2025 was more than what a typical Neuro-Ophthalmology provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $95.47 · 2021: $301 · 2022: $861 · 2023: $1,161 · 2024: $690 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,505 · Education: $35.95 · Travel and Lodging: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,504.61 |
| Education | $35.95 |
| Travel and Lodging | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,035.24 | 2022-2023 | Tepezza |
| Amgen INC. | $690.79 | 2024-2025 | Tepezza, Uplizna |
| Alexion Pharmaceuticals, INC. | $561.34 | 2019-2025 | Ultomiris |
| Abbvie INC. | $414.23 | 2022-2025 | |
| Argenx US, INC. | $360.03 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Allergan, INC. | $310.68 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $273.33 | 2021-2024 | Xeomin |
| Ucb, INC. | $240.33 | 2023-2024 | Zilbrysq |
| Alcon Vision LLC | $133.33 | 2019-2025 | Clareon, Total30 |
| Mallinckrodt Enterprises LLC | $119.58 | 2019 | |
| Merz North America, INC. | $60.67 | 2019-2020 | |
| Abb Con-Cise Optical Group LLC | $46.07 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $44.37 | 2024 | Lipiflow System Activator (Disposable), Meibomian Gland Evaluator |
| Recordati_rare_diseases_inc. | $19.59 | 2023 | Cystadrops |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.